GLIMILOC PG1 Tablets | For Blood Sugar Management

Description

Product Description

GLIMILOC PG1 Tablets contain Glimepiride 2 mg and Pioglitazone 15 mg, a combination medication commonly prescribed to help manage type 2 diabetes mellitus and support effective blood sugar control.

This bilayered tablet formulation works by stimulating insulin release from the pancreas and improving the body’s sensitivity to insulin. When taken under proper medical supervision, it helps maintain stable blood glucose levels and supports overall metabolic health.

Uses

• Helps manage type 2 diabetes mellitus
• Supports better blood sugar control
• Helps improve insulin sensitivity
• Supports overall metabolic health

Benefits

• Helps lower blood glucose levels
• Supports improved glycemic control
• Helps reduce blood sugar fluctuations
• Contributes to effective diabetes management

Composition

Glimepiride – 2 mg
Glimepiride is a sulfonylurea antidiabetic medicine that helps stimulate the pancreas to release insulin and control blood sugar levels.

Pioglitazone – 15 mg
Pioglitazone is a thiazolidinedione antidiabetic medicine that helps improve the body’s response to insulin and maintain healthy blood glucose levels.

Dosage

• Take as directed by a healthcare professional
• Swallow the tablet with water after meals or as advised by your doctor
• Do not exceed the recommended dosage

Side Effects

Some individuals may experience mild side effects such as:

• Nausea
• Dizziness
• Weight gain
• Low blood sugar (hypoglycemia)

If any side effects persist or worsen, consult a healthcare professional.

Storage

• Store in a cool and dry place
• Protect from direct sunlight
• Keep out of reach of children

Safety Information

• Use only under medical supervision
• Do not exceed the recommended dosage
• Inform your doctor about existing medical conditions or medications before use